ResMed Inc. (0KW4.L)
USD 239.46
(1.1%)
USD 239.46
(1.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.68 Billion USD | 10.95% |
| 2023 | 4.22 Billion USD | 18.02% |
| 2022 | 3.57 Billion USD | 11.93% |
| 2021 | 3.19 Billion USD | 8.11% |
| 2020 | 2.95 Billion USD | 13.44% |
| 2019 | 2.6 Billion USD | 11.38% |
| 2018 | 2.34 Billion USD | 13.23% |
| 2017 | 2.06 Billion USD | 12.4% |
| 2016 | 1.83 Billion USD | 9.52% |
| 2015 | 1.67 Billion USD | 7.97% |
| 2014 | 1.55 Billion USD | 2.68% |
| 2013 | 1.51 Billion USD | 10.66% |
| 2012 | 1.36 Billion USD | 10.08% |
| 2011 | 1.24 Billion USD | 13.8% |
| 2010 | 1.09 Billion USD | 18.64% |
| 2009 | 920.73 Million USD | 10.22% |
| 2008 | 835.39 Million USD | 16.62% |
| 2007 | 716.33 Million USD | 18.01% |
| 2006 | 606.99 Million USD | 42.65% |
| 2005 | 425.5 Million USD | 25.39% |
| 2004 | 339.33 Million USD | 24.04% |
| 2003 | 273.57 Million USD | 34.05% |
| 2002 | 204.07 Million USD | 31.53% |
| 2001 | 155.15 Million USD | 34.2% |
| 2000 | 115.61 Million USD | 30.49% |
| 1999 | 88.6 Million USD | 33.23% |
| 1998 | 66.5 Million USD | 35.16% |
| 1997 | 49.2 Million USD | 42.2% |
| 1996 | 34.6 Million USD | 47.23% |
| 1995 | 23.5 Million USD | 69.06% |
| 1994 | 13.9 Million USD | 80.52% |
| 1993 | 7.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 4.68 Billion USD | 10.95% |
| 2024 Q2 | 1.16 Billion USD | 20.74% |
| 2024 Q1 | 963.03 Million USD | -14.17% |
| 2024 Q4 | 1.22 Billion USD | 2.19% |
| 2024 Q3 | 1.19 Billion USD | 2.94% |
| 2023 Q2 | 1.03 Billion USD | 8.78% |
| 2023 FY | 4.22 Billion USD | 18.02% |
| 2023 Q4 | 1.12 Billion USD | 0.46% |
| 2023 Q1 | 950.29 Million USD | 3.89% |
| 2023 Q3 | 1.11 Billion USD | 8.04% |
| 2022 Q1 | 904.01 Million USD | 3.19% |
| 2022 FY | 3.57 Billion USD | 11.93% |
| 2022 Q4 | 914.73 Million USD | 5.81% |
| 2022 Q3 | 864.5 Million USD | -3.39% |
| 2022 Q2 | 894.87 Million USD | -1.01% |
| 2021 Q1 | 751.94 Million USD | -2.39% |
| 2021 Q3 | 768.76 Million USD | -3.91% |
| 2021 FY | 3.19 Billion USD | 8.11% |
| 2021 Q2 | 800.01 Million USD | 6.39% |
| 2021 Q4 | 876.1 Million USD | 13.96% |
| 2020 Q2 | 736.15 Million USD | 8.09% |
| 2020 Q4 | 770.34 Million USD | 0.12% |
| 2020 FY | 2.95 Billion USD | 13.44% |
| 2020 Q3 | 769.45 Million USD | 4.52% |
| 2020 Q1 | 681.05 Million USD | -3.39% |
| 2019 Q2 | 651.1 Million USD | 10.68% |
| 2019 Q4 | 704.96 Million USD | 6.45% |
| 2019 Q1 | 588.27 Million USD | -5.67% |
| 2019 Q3 | 662.22 Million USD | 1.71% |
| 2019 FY | 2.6 Billion USD | 11.38% |
| 2018 Q2 | 601.27 Million USD | 14.82% |
| 2018 FY | 2.34 Billion USD | 13.23% |
| 2018 Q4 | 623.63 Million USD | 5.41% |
| 2018 Q1 | 523.65 Million USD | -5.93% |
| 2018 Q3 | 591.63 Million USD | -1.6% |
| 2017 Q3 | 514.2 Million USD | -3.05% |
| 2017 Q2 | 530.39 Million USD | 13.95% |
| 2017 Q4 | 556.68 Million USD | 8.26% |
| 2017 FY | 2.06 Billion USD | 12.4% |
| 2017 Q1 | 465.45 Million USD | -10.26% |
| 2016 Q3 | 453.87 Million USD | -0.15% |
| 2016 Q2 | 454.54 Million USD | 10.42% |
| 2016 Q1 | 411.64 Million USD | -9.14% |
| 2016 FY | 1.83 Billion USD | 9.52% |
| 2016 Q4 | 518.64 Million USD | 14.27% |
| 2015 FY | 1.67 Billion USD | 7.97% |
| 2015 Q4 | 453.06 Million USD | 7.23% |
| 2015 Q3 | 422.49 Million USD | -0.11% |
| 2015 Q1 | 380.39 Million USD | -8.38% |
| 2015 Q2 | 422.95 Million USD | 11.19% |
| 2014 Q4 | 415.21 Million USD | 4.39% |
| 2014 Q2 | 384.34 Million USD | 7.46% |
| 2014 Q1 | 357.66 Million USD | -13.73% |
| 2014 FY | 1.55 Billion USD | 2.68% |
| 2014 Q3 | 397.75 Million USD | 3.49% |
| 2013 Q1 | 339.73 Million USD | -8.66% |
| 2013 Q4 | 414.6 Million USD | 8.09% |
| 2013 FY | 1.51 Billion USD | 10.66% |
| 2013 Q3 | 383.58 Million USD | 1.87% |
| 2013 Q2 | 376.53 Million USD | 10.83% |
| 2012 Q3 | 349.07 Million USD | 4.91% |
| 2012 Q4 | 371.92 Million USD | 6.55% |
| 2012 Q1 | 314.77 Million USD | -7.93% |
| 2012 Q2 | 332.73 Million USD | 5.71% |
| 2012 FY | 1.36 Billion USD | 10.08% |
| 2011 Q2 | 305.98 Million USD | 8.5% |
| 2011 Q1 | 282.01 Million USD | -3.28% |
| 2011 FY | 1.24 Billion USD | 13.8% |
| 2011 Q4 | 341.89 Million USD | -62.06% |
| 2011 Q3 | 901.25 Million USD | 194.54% |
| 2010 Q3 | 278.65 Million USD | 1.28% |
| 2010 Q2 | 275.13 Million USD | 11.39% |
| 2010 Q1 | 246.99 Million USD | -1.97% |
| 2010 FY | 1.09 Billion USD | 18.64% |
| 2010 Q4 | 291.57 Million USD | 4.63% |
| 2009 Q3 | 227.86 Million USD | 2.19% |
| 2009 Q2 | 222.98 Million USD | 2.32% |
| 2009 Q1 | 217.93 Million USD | -7.32% |
| 2009 FY | 920.73 Million USD | 10.22% |
| 2009 Q4 | 251.95 Million USD | 10.57% |
| 2008 Q1 | 185.74 Million USD | -2.91% |
| 2008 FY | 835.39 Million USD | 16.62% |
| 2008 Q4 | 235.15 Million USD | 11.01% |
| 2008 Q3 | 211.82 Million USD | 4.51% |
| 2008 Q2 | 202.67 Million USD | 9.12% |
| 2007 Q1 | 163.6 Million USD | -4.42% |
| 2007 FY | 716.33 Million USD | 18.01% |
| 2007 Q3 | 182.99 Million USD | 2.56% |
| 2007 Q2 | 178.42 Million USD | 9.06% |
| 2007 Q4 | 191.3 Million USD | 4.55% |
| 2006 Q2 | 146.41 Million USD | 15.17% |
| 2006 FY | 606.99 Million USD | 42.65% |
| 2006 Q1 | 127.12 Million USD | 1.36% |
| 2006 Q4 | 171.17 Million USD | 5.48% |
| 2006 Q3 | 162.28 Million USD | 10.83% |
| 2005 Q2 | 103.89 Million USD | 18.42% |
| 2005 Q4 | 125.42 Million USD | 15.65% |
| 2005 FY | 425.5 Million USD | 25.39% |
| 2005 Q3 | 108.45 Million USD | 4.39% |
| 2005 Q1 | 87.73 Million USD | -5.55% |
| 2004 Q4 | 92.89 Million USD | 1.77% |
| 2004 Q1 | 72.87 Million USD | -9.69% |
| 2004 Q3 | 91.27 Million USD | 10.92% |
| 2004 FY | 339.33 Million USD | 24.04% |
| 2004 Q2 | 82.29 Million USD | 12.92% |
| 2003 Q1 | 58.58 Million USD | 4.16% |
| 2003 Q3 | 68.99 Million USD | 5.67% |
| 2003 Q2 | 65.29 Million USD | 11.45% |
| 2003 FY | 273.57 Million USD | 34.05% |
| 2003 Q4 | 80.69 Million USD | 16.96% |
| 2002 Q2 | 48.92 Million USD | 6.06% |
| 2002 Q4 | 56.24 Million USD | 6.58% |
| 2002 FY | 204.07 Million USD | 31.53% |
| 2002 Q3 | 52.77 Million USD | 7.87% |
| 2002 Q1 | 46.12 Million USD | -1.91% |
| 2001 Q2 | 34.36 Million USD | 10.57% |
| 2001 Q4 | 47.02 Million USD | 10.19% |
| 2001 FY | 155.15 Million USD | 34.2% |
| 2001 Q1 | 31.08 Million USD | -1.53% |
| 2001 Q3 | 42.68 Million USD | 24.19% |
| 2000 Q1 | 25.9 Million USD | 3.19% |
| 2000 Q2 | 28.1 Million USD | 8.49% |
| 2000 Q4 | 31.56 Million USD | 5.32% |
| 2000 Q3 | 29.97 Million USD | 6.66% |
| 2000 FY | 115.61 Million USD | 30.49% |
| 1999 Q4 | 25.1 Million USD | 10.09% |
| 1999 FY | 88.6 Million USD | 33.23% |
| 1999 Q1 | 19.2 Million USD | -0.52% |
| 1999 Q2 | 21.5 Million USD | 11.98% |
| 1999 Q3 | 22.8 Million USD | 6.05% |
| 1998 Q1 | 14 Million USD | 0.0% |
| 1998 Q4 | 19.3 Million USD | 12.87% |
| 1998 Q3 | 17.1 Million USD | 6.21% |
| 1998 Q2 | 16.1 Million USD | 15.0% |
| 1998 FY | 66.5 Million USD | 35.16% |
| 1997 Q2 | 11.6 Million USD | 4.5% |
| 1997 Q1 | 11.1 Million USD | 4.72% |
| 1997 Q3 | 12.5 Million USD | 7.76% |
| 1997 Q4 | 14 Million USD | 12.0% |
| 1997 FY | 49.2 Million USD | 42.2% |
| 1996 FY | 34.6 Million USD | 47.23% |
| 1996 Q4 | 10.6 Million USD | 12.77% |
| 1996 Q3 | 9.4 Million USD | 18.99% |
| 1996 Q1 | 6.7 Million USD | 0.0% |
| 1996 Q2 | 7.9 Million USD | 17.91% |
| 1995 Q1 | 5.6 Million USD | 64.71% |
| 1995 Q3 | 5.6 Million USD | 0.0% |
| 1995 Q4 | 6.7 Million USD | 19.64% |
| 1995 FY | 23.5 Million USD | 69.06% |
| 1995 Q2 | 5.6 Million USD | 0.0% |
| 1994 FY | 13.9 Million USD | 80.52% |
| 1994 Q4 | 3.4 Million USD | -2.86% |
| 1994 Q2 | 3.5 Million USD | 0.0% |
| 1994 Q1 | 3.5 Million USD | 75.0% |
| 1994 Q3 | 3.5 Million USD | 0.0% |
| 1993 Q1 | 1.9 Million USD | 0.0% |
| 1993 Q4 | 2 Million USD | 5.26% |
| 1993 Q3 | 1.9 Million USD | 0.0% |
| 1993 Q2 | 1.9 Million USD | 0.0% |
| 1993 FY | 7.7 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -1214.99% |
| Accuray Incorporated | 446.55 Million USD | -949.219% |
| Align Technology, Inc. | 3.86 Billion USD | -21.31% |
| Elevance Health Inc. | 171.34 Billion USD | 97.265% |
| AxoGen, Inc. | 159.01 Million USD | -2846.505% |
| Boston Scientific Corporation | 14.24 Billion USD | 67.098% |
| CVS Health Corporation | 357.77 Billion USD | 98.69% |
| Cardinal Health, Inc. | 226.82 Billion USD | 97.934% |
| Centene Corporation | 141.26 Billion USD | 96.683% |
| DaVita Inc. | 12.14 Billion USD | 61.407% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 92.788% |
| Hologic, Inc. | 4.03 Billion USD | -16.252% |
| Humana Inc. | 106.37 Billion USD | 95.595% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -27.98% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 61.475% |
| Masimo Corporation | 2.04 Billion USD | -128.763% |
| McKesson Corporation | 308.95 Billion USD | 98.483% |
| Patterson Companies, Inc. | 6.56 Billion USD | 28.668% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 49.359% |
| Henry Schein, Inc. | 12.33 Billion USD | 62.029% |
| Teladoc Health, Inc. | 2.6 Billion USD | -80.037% |
| Universal Health Services, Inc. | 14.28 Billion USD | 67.194% |
| Veeva Systems Inc. | 2.36 Billion USD | -98.221% |
| Baxter International Inc. | 14.81 Billion USD | 68.37% |
| Becton, Dickinson and Company | 19.37 Billion USD | 75.814% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 34.233% |
| Danaher Corporation | 23.89 Billion USD | 80.388% |
| Stryker Corporation | 20.49 Billion USD | 77.143% |
| Medtronic plc | 32.36 Billion USD | 85.523% |